Good News: Levamlodipine Besylate API Obtains Approval-Newland Pharmaceutical Co., Ltd.

快捷导航

当前位置：首页 ›› 快捷导航 ›› News

Good News: Levamlodipine Besylate API Obtains Approval

Release Date：2026-06-23 17:02:10 Views：2877

Good News: Levamlodipine Besylate API Obtains Approval

Previous Article：Everyone Prioritizes Safety, Everyone Masters Emergency Response Newland Pharmaceutical Successfully Concludes the 2026 Work Safety Month Next Article：Newland Pharmaceutical Successfully Concludes the Event CPHI & PMEC China 2026

About Us

Profile
Culture
Cultural Activities

News
Contact Us

Address：East Side, South Weiwu Rd, Changge

Tel：86-374-6105083 6105858

Fax：86-374-6105388
Follow Us